ENTA - Enanta Pharma EPS misses by $0.52 misses on revenue November, 23 2020 04:06 PM Enanta Pharmaceuticals Inc. Enanta Pharma (ENTA): Q4 GAAP EPS of -$1.46 misses by $0.52.Revenue of $23.6M (-54.0% Y/Y) misses by $2.16M.2021 Guidance: R&D Expense $145M-165M; G&A Expense $27M-33MPress Release For further details see: Enanta Pharma EPS misses by $0.52, misses on revenue